Spectral Genomics, Inc. Names GE Healthcare as Its Exclusive International Distributor


Spectral Genomics, Inc.(R) announced the appointment of GE Healthcare as its exclusive international distributor to the research market for Spectral Genomics products outside the US and Canada. Spectral will continue to sell its products to certain clinical diagnostic customers outside North America.

Spectral Genomics develops and manufactures BAC clone microarrays with applications in molecular karyotyping for genetic defects, cancer, and human polymorphisms with further applications in drug discovery and personalized medicine.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances